Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure

Abstract

Our data further denote that miRNAs are potential biomarkers for systolic heart failure. Since their detection levels in whole blood are also related to the degree of left ventricular dysfunction, they may serve as objective molecular tools to assess disease severity and prognosis.